BIOGEN INC. Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net
BIOGEN INC. (BIIB) had Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net of $1.70 million as of 2012-12-31, per its 10-K filed 2013-02-05.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet · last filed 2013-02-05
- 2012-12-31: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net $1.70M.
- 2012-09-30: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net $4.30M.
- 2012-06-30: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net $500.00K.
- 2012-03-31: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net $2.00M.
| Period end | Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net |
|---|---|
| 2012-12-31 | $1.70M 10-K · filed 2013-02-05 |
| 2012-09-30 | $4.30M 10-Q · filed 2012-10-25 |
| 2012-06-30 | $500.00K 10-Q · filed 2012-07-24 |
| 2012-03-31 | $2.00M 10-Q · filed 2012-05-01 |
| 2011-12-31 | $6.40M 10-K · filed 2013-02-05 |
| 2011-09-30 | $6.50M 10-Q · filed 2011-10-28 |
| 2011-06-30 | $700.00K 10-Q · filed 2011-07-26 |
| 2011-03-31 | $2.30M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $100.00K 10-K · filed 2012-02-03 |
| 2010-09-30 | $7.00M 10-Q · filed 2010-10-26 |
| 2010-06-30 | $1.70M 10-Q · filed 2010-07-20 |
| 2009-12-31 | $3.80M 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |